Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation

Area of Science:

• Immunology
• Cardiovascular Medicine
• Virology

Background:

• Growing reports link COVID-19 recovery to subsequent vascular events.
• Endothelial cells (CECs) are crucial for vascular health and their dysfunction indicates injury.
• Pre-existing conditions may exacerbate post-COVID-19 vascular complications.

Purpose of the Study:

• To investigate the long-term impact of COVID-19 on vascular health in recovered patients.
• To identify biomarkers of vascular injury and dysfunction post-COVID-19.
• To explore the role of immune responses in post-COVID-19 vascular complications.

Main Methods:

• Quantification of circulating endothelial cells (CECs) in COVID-19 convalescents versus healthy controls.
• Assessment of endothelial activation markers and cytokine profiles.
• Analysis of T lymphocyte populations, including effector T cells and their interaction with CECs.

Main Results:

• Elevated CEC levels observed in COVID-19 convalescents, signifying vascular injury.
• More pronounced endothelial activation in convalescents with pre-existing conditions (hypertension, diabetes).
• Sustained pro-inflammatory cytokines correlated with CEC levels, indicating cytokine-driven endothelial dysfunction.
• Increased frequency of effector T cells in convalescents, with activation markers suggesting potential targeting of endothelial cells by cytotoxic CD8+ T cells.

Conclusions:

• COVID-19 infection leads to persistent vascular injury and endothelial dysfunction, even after recovery.
• Immune responses, particularly involving effector T cells and cytokines, play a significant role in post-COVID-19 vascular complications.
• Preventive therapeutic strategies may be necessary to mitigate long-term vascular risks in COVID-19 survivors.